| human | Q5 |
| P496 | ORCID iD | 0000-0002-7268-8559 |
| P734 | family name | Heinzen | Q37481601 |
| Heinzen | Q37481601 | ||
| Heinzen | Q37481601 | ||
| P735 | given name | Erin | Q770100 |
| Erin | Q770100 | ||
| P106 | occupation | researcher | Q1650915 |
| Q47169309 | A case-control collapsing analysis identifies epilepsy genes implicated in trio sequencing studies focused on de novo mutations |
| Q34768431 | A genome-wide comparison of the functional properties of rare and common genetic variants in humans |
| Q33406258 | A genome-wide investigation of SNPs and CNVs in schizophrenia |
| Q24644827 | A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB |
| Q35766082 | A whole-genome analysis of premature termination codons |
| Q35794427 | Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease |
| Q55128222 | Analysis of shared heritability in common disorders of the brain |
| Q38631591 | Annotating pathogenic non-coding variants in genic regions |
| Q91997808 | Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract |
| Q92610618 | Autism and developmental disability caused by KCNQ3 gain-of-function variants |
| Q36094652 | Clinical profile of patients with ATP1A3 mutations in Alternating Hemiplegia of Childhood-a study of 155 patients |
| Q28943476 | Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study |
| Q57323037 | Correction: A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia |
| Q46085643 | De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures |
| Q54534163 | De novo and inherited private variants in MAP1B in periventricular nodular heterotopia. |
| Q24600468 | De novo mutations in ATP1A3 cause alternating hemiplegia of childhood |
| Q24621776 | De novo mutations in epileptic encephalopathies |
| Q35901103 | Differential gene expression in dentate granule cells in mesial temporal lobe epilepsy with and without hippocampal sclerosis |
| Q34546995 | Distinct neurological disorders with ATP1A3 mutations |
| Q36766098 | Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis. |
| Q33881325 | Ethical challenges in genotype-driven research recruitment |
| Q36439344 | Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome |
| Q24620622 | Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy |
| Q36152879 | Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia |
| Q30457108 | Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG). |
| Q28255243 | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance |
| Q31129974 | Genic intolerance to functional variation and the interpretation of personal genomes |
| Q33535874 | Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals |
| Q34257932 | Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions |
| Q33906177 | Genome-wide scan of copy number variation in late-onset Alzheimer's disease |
| Q36101281 | Genomic microdeletions associated with epilepsy: not a contraindication to resective surgery |
| Q36891139 | Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures |
| Q34172669 | HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans |
| Q28115754 | Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy |
| Q37152978 | Mutations of the Sonic Hedgehog Pathway Underlie Hypothalamic Hamartoma with Gelastic Epilepsy |
| Q64042824 | NBEA: Developmental disease gene with early generalized epilepsy phenotypes |
| Q44347872 | Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor |
| Q35752646 | Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A. |
| Q40142515 | Postmortem delay has minimal effect on brain RNA integrity |
| Q38844503 | Primer Part 1-The building blocks of epilepsy genetics |
| Q36439331 | Prioritizing genetic variants for causality on the basis of preferential linkage disequilibrium |
| Q33847202 | Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes |
| Q33651270 | SLC25A22 is a novel gene for migrating partial seizures in infancy. |
| Q34188360 | SVA: software for annotating and visualizing sequenced human genomes |
| Q33965942 | Screening the human exome: a comparison of whole genome and whole transcriptome sequencing |
| Q52573138 | Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. |
| Q41773363 | Somatic activation of AKT3 causes hemispheric developmental brain malformations |
| Q41369944 | Somatic uniparental disomy of Chromosome 16p in hemimegalencephaly. |
| Q33691366 | The characterization of twenty sequenced human genomes |
| Q90712113 | The copy number variation landscape of congenital anomalies of the kidney and urinary tract |
| Q38404155 | The genetics of neuropsychiatric diseases: looking in and beyond the exome |
| Q33409947 | Tissue-specific genetic control of splicing: implications for the study of complex traits |
| Q24604693 | Using ERDS to infer copy-number variants in high-coverage genomes |
| Q34000914 | Utilizing population controls in rare-variant case-parent association tests |
Search more.